VCEL Vericel Corporation

3.20
+0.20  (7%)
Previous Close 3.00
Open 3.00
Price To book 6.33
Market Cap 104.85M
Shares 32,766,000
Volume 944,414
Short Ratio 9.58
Av. Daily Volume 237,320

SEC filingsSee all SEC filings

  1. 8-K/A [Amend] - Current report 17888009
  2. 8-K/A [Amend] - Current report 17887972
  3. 8-K/A [Amend] - Current report 17887915
  4. 8-K - Current report 17857834
  5. 8-K - Current report 17846124

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2b topline data released March 2016. Full data released April 2016
ixmyelocel-T
Stem cells - Dilated Cardiomyopathy
FDA Approval announced December 13, 2016 ahead of PDUFA date of January 3 2017.
MACI
Focal chondral cartilage defects in the knee.

SEC Filings

  1. 8-K/A [Amend] - Current report 17888009
  2. 8-K/A [Amend] - Current report 17887972
  3. 8-K/A [Amend] - Current report 17887915
  4. 8-K - Current report 17857834
  5. 8-K - Current report 17846124
  6. 10-Q - Quarterly report [Sections 13 or 15(d)] 17831135
  7. 8-K - Current report 17828558
  8. 8-K - Current report 17818996
  9. S-8 - Securities to be offered to employees in employee benefit plans 17818935
  10. DEF 14A - Other definitive proxy statements 17702014